Sublancin alleviates Salmonella typhimurium-induced colitis and balances gut bacterial dysbiosis in mice

文献类型： 外文期刊

第一作者： Yang, Yanzhi

作者： Yang, Yanzhi;Guo, Bingyu;Chen, Siyuan;Song, Tongxing;Xu, Chuanhui;Song, Tongxing

作者机构：

关键词： Colitis; Sublancin; Gut microbiota; Inflammation; Salmonella typhimurium

期刊名称：ARCHIVES OF MICROBIOLOGY （ 影响因子：2.6； 五年影响因子：2.8 ）

ISSN： 0302-8933

年卷期： 2025 年 207 卷 9 期

页码：

收录情况： SCI

摘要： Bacterial infection is the main cause of acute colitis with Salmonella typhimurium being a common culprit. However, there is a lack of research on the safe and efficient therapy for S. typhimurium-induced colitis. Sublancin, an antimicrobial peptide (AMP), is supposed to have strong antibacterial activity and low susceptibility to resistance. Therefore, this study aimed to investigate the effect of sublancin on S. typhimurium-induced colitis. An acute colitis model was established by S. typhimurium infection in mice. The therapy was administered by oral gavage. The trial was divided into four groups: control (Con), infection (Inf), low concentration of sublancin (L-Sub) and high concentration of sublancin (H-Sub). After 3 days of treatment, H-Sub group exhibited ameliorated body weight loss and improved colon tissue morphology compared to Inf group. Moreover, there was a notable decrease in the inflammatory response and an alleviation of the intestinal epithelial barrier damage in the colons of H-Sub group compared to Inf group. Consistently, high-dose sublancin also reduced the weight and bacterial load of spleen and liver after S. typhimurium attack. Mechanically, gut microbiota analysis performed by 16 S rRNA gene seq revealed that sublancin balanced microbial dysbiosis in colonic content, suggesting that increased Paramuribaculum, Clostridium_AQ and decreased Muribaculum may response to sublancin. These findings may help providing a new therapy of AMP in bacterial colitis.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序